SREE HARITHA CHALASANI
** **.******** ******, *** # 8, Boston, MA 02115? (617) 515-
1872?**********.*********@*****.***
SUMMARY OF QUALIFICATIONS
. Strong working knowledge of Formulation Development, Validation and
Scale-Up.
. Excellent knowledge in solid oral dosage form manufacturing processes
such as wet granulation, extrusion spheronization, compression and
coating.
. Effective team player and multi-tasker. Easily adapts to changing
work requirements and environments.
. Broad skill-set in analytical equipment including Liquid
chromatograph - Mass Spectrometer (LC-MS) with Electron Spray
Ionization and Atmospheric pressure chemical ionization, Gas
chromatography (GC), and High Performance Liquid Chromatograph (HPLC)
. Experienced in working with small animals including rats and mice.
PROFESSIONAL EXPERIENCE
Vertex Pharmaceuticals, Cambridge, MA May
2010-present
Sr. Scientific Associate, Formulation Development
Formulation Development
. Developed an immediate release granule formulation by extrusion
spheronization. Worked on Wurster coating to obtain controlled
release formulation from the granules with tunable release profiles.
. Developed a controlled release formulation using high-shear
granulator.
. Performed characterization of key physical properties that influence
downstream processing.
Analytical Development
. Estimated the release profile of the prepared formulations in
different media using USP IV flow-through apparatus.
Center for Drug Discovery, Northeastern University, Boston, MA
January 2009 - May 2010
Research Assistant,
In Vitro-In Vivo Drug Metabolism Studies using CYP450
. Identified metabolites of CYP450, and determined their intrinsic and
hepatic clearance by in vitro metabolism studies. Analysis carried
out by LC-MS.
. Performed in vivo studies in mice: Cassette dosing by oral and
intravenous routes. Clearance of metabolites of CYP450 was
determined.
. Established an in-vitro in-vivo correlation.
Receptor Binding Assays
. Prepared synaptosomal membranes from rat brain. Estimated membrane
protein concentration using Bradford Protein Assay.
. Maintained two HEK 293 (Human Embryonic Kidney) Cell lines
transfected with two Cannabinoid receptors. Isolated cannabinoid
receptors by cell lysis.
. Carried out 96 well plate-based high throughput screening with
radioactive labeled materials.
. Performed assays like Saturation Binding Assay, Competition Binding
Assay and Covalent Binding Assay to screen novel chemical entities
for their potency and selectivity. Analyzed data using GraphPad Prism
software and interpreted results.
. Documented study results, and presented conclusions in biweekly group
meetings.
. Performed functional Assays like GTP?S Assay, cAMP Assay, and MAP
Kinase Assay.
. Trained undergraduate students, graduate students with these
techniques.
Dr.Reddy's Laboratories, Hyderabad, India
January 2008 - June 2008
Project Intern, Product Development
Product and Process Optimization
. Optimized the composition of a tablet formulation using design of
experiments (DOE). Evaluated the influence of each excipient on the
physical properties of the tablets.
. Optimized key process parameters including fluid intake, kneading
speed, drying temperature, percentage loss on drying (LOD), dried
granule size, punch penetration and force, and stress effects on
coating at bench-scale. The granulation end point was detected using
torque sensors.
. Validated and scaled up the tablet formulation to pilot-scale.
Batches with the optimum composition were prepared, validated and
scaled up to pilot-scale.
. Achieved a direct correlation from bench to pilot scale by utilizing
equipment parameters and batch size.
Genix Pharmaceuticals, Hyderabad, India
May 2006 - July 2006
Project Intern
. Learned the basic principles of HPLC and GC.
. Analyzed samples of manufactured drug substance using HPLC and GC.
ACADEMIC EXPERIENCE
Birla Institute of Technology and Science, Pilani
January 2007- December 2007
Undergraduate Student
Controlled Drug Delivery Systems
. Formulated gelatin microcapsules for controlled drug delivery for an
external partner. Risperidone was microencapsulated by precipitating
gelatin on solubilized drug particles.
. Optimized trapping efficiency of the drug by varying excipient
levels.
. Developed in-house UV visible spectrophotometric method to determine
the drug concentrations.
. Evaluated the release profile by dissolution studies over extended
periods of 24 hours.
Quantitative Structure Activity Relationships (QSAR) and Quantitative
Structure Pharmacokinetic Relationship (QSPkR)
. Investigated various descriptors and software used in determining the
QSAR and QSPkR relations.
EDUCATION
Northeastern University, Boston, MA
May 2010
Master of Science in Pharmaceutical Sciences, Specialization:
Pharmaceutics and Drug Delivery Systems.
Birla Institute of Technology and Science, Pilani, India
June 2008
Bachelor of Pharmacy (Hons.), June 2008
Major GPA: 3.85/4.0
Relevant Coursework
Mass Spectrometry, Pharmacokinetics, Biopharmaceutics, Advanced Physical
Pharmacy, Biochemistry, Molecular Cell Biology, Pharmacoeconomics,
Biostatistics.
AWARDS AND HONORS
. Awarded the Gold medal for "BEST B.PHARMACY (Hons.) GRADUATE" at Birla
Institute of
Technology and Science, Pilani, India.
. Received the Merit Scholarship at Birla Institute of Technology and
Science, Pilani, India.
. Recipient of the prestigious Scholarship from the Government of India
for academic excellence.
SOFTWARE EXPERTISE
GraphPad Prism, SPSS software, Umetrics Software, Word, Excel, PowerPoint,
Outlook.